Microbiome- And Host Inflammasome-targeting Inhibitor Nanoligomers Are Therapeutic In The Murine Colitis Model
View Original Source →Abstract
model. Overall, these results point to the potential for further development and testing of this inflammasome-targeting host-directed therapy (NI112) and more personalized microbiome cocktails (CK1) for patients with recalcitrant IBD.
Case Details
No case details have been reported for this case.
Treatment & Mechanisms
No treatment or mechanism details have been reported for this case.